AYTU – aytu biopharma, inc. (US:NASDAQ)

News

Aytu BioPharma (AYTU) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Aytu BioPharma (AYTU) was downgraded by Zacks Research from "hold" to "strong sell".
Aytu BioPharma (AYTU) was upgraded by Zacks Research from "strong sell" to "hold".
Aytu BioPharma Inc (AYTU) Q2 2026 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com